BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9301671)

  • 1. Inhibition of melanoma cell binding to type IV collagen by analogs of cell adhesion regulator.
    Lauer JL; Furcht LT; Fields GB
    J Med Chem; 1997 Sep; 40(19):3077-84. PubMed ID: 9301671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An all-D amino acid peptide model of alpha1(IV)531-543 from type IV collagen binds the alpha3beta1 integrin and mediates tumor cell adhesion, spreading, and motility.
    Li C; McCarthy JB; Furcht LT; Fields GB
    Biochemistry; 1997 Dec; 36(49):15404-10. PubMed ID: 9398270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of CD47/integrin-associated protein and alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells.
    Shahan TA; Ziaie Z; Pasco S; Fawzi A; Bellon G; Monboisse JC; Kefalides NA
    Cancer Res; 1999 Sep; 59(18):4584-90. PubMed ID: 10493512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ligand conformation on melanoma cell alpha3beta1 integrin-mediated signal transduction events: implications for a collagen structural modulation mechanism of tumor cell invasion.
    Lauer JL; Gendron CM; Fields GB
    Biochemistry; 1998 Apr; 37(15):5279-87. PubMed ID: 9548759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic peptides inhibit adhesion of human tumor cells to extracellular matrix proteins.
    DeRoock IB; Pennington ME; Sroka TC; Lam KS; Bowden GT; Bair EL; Cress AE
    Cancer Res; 2001 Apr; 61(8):3308-13. PubMed ID: 11309285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering integrin-specific surfaces with a triple-helical collagen-mimetic peptide.
    Reyes CD; García AJ
    J Biomed Mater Res A; 2003 Jun; 65(4):511-23. PubMed ID: 12761842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between endothelial cells and basement membrane components. In vitro studies on endothelial cell adhesion to collagen types I, III, IV and high molecular weight fragments of IV.
    Rixen H; Kirkpatrick CJ; Schmitz U; Ruchatz D; Mittermayer C
    Exp Cell Biol; 1989; 57(6):315-23. PubMed ID: 2535276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent cyclic peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion. Discovery of compounds like cyclo(MePhe-Leu-Asp-Val-D-Arg-D-Arg) (ZD7349) compatible with depot formulation.
    Dutta AS; Gormley JJ; Coath M; Hassall L; Hayward CF; Gellert PR; Kittlety RS; Alcock PJ; Ferguson R; Halterman T; Jamieson A; Moors JA; Moores JM; Rees A; Wood LJ; Reilly CF; Haworth D
    J Pept Sci; 2000 Aug; 6(8):398-412. PubMed ID: 10969869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro effects of SIKVAV retro and retro-enantio analogues on tumor metastatic events.
    Almiñana N; Grau-Oliete MR; Reig F; Rivera-Fillat MP
    Peptides; 2004 Feb; 25(2):251-9. PubMed ID: 15063006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide array-based interaction assay of solid-bound peptides and anchorage-dependant cells and its effectiveness in cell-adhesive peptide design.
    Kato R; Kaga C; Kunimatsu M; Kobayashi T; Honda H
    J Biosci Bioeng; 2006 Jun; 101(6):485-95. PubMed ID: 16935250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different adhesion properties of highly and poorly metastatic HT-29 colon carcinoma cells with extracellular matrix components: role of integrin expression and cytoskeletal components.
    Haier J; Nasralla M; Nicolson GL
    Br J Cancer; 1999 Aug; 80(12):1867-74. PubMed ID: 10471033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the extracellular matrix proteins in the resistance of SP6.5 uveal melanoma cells toward cisplatin.
    Bérubé M; Talbot M; Collin C; Paquet-Bouchard C; Germain L; Guérin SL; Petitclerc E
    Int J Oncol; 2005 Feb; 26(2):405-13. PubMed ID: 15645125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type IV collagen and corneal epithelial adhesion and migration. Effects of type IV collagen fragments and synthetic peptides on rabbit corneal epithelial cell adhesion and migration in vitro.
    Cameron JD; Skubitz AP; Furcht LT
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2766-73. PubMed ID: 1894474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of collagen IV on neuroblastoma cell matrix-related functions.
    Tzinia AK; Kitsiou PV; Talamagas AA; Georgopoulos A; Tsilibary EC
    Exp Cell Res; 2002 Apr; 274(2):169-77. PubMed ID: 11900477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent cyclic monomeric and dimeric peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion based on the Ile-Leu-Asp-Val tetrapeptide.
    Dutta AS; Crowther M; Gormley JJ; Hassall L; Hayward CF; Gellert PR; Kittlety RS; Alcock PJ; Jamieson A; Moores JM; Rees A; Wood LJ; Reilly CF; Haworth D
    J Pept Sci; 2000 Jul; 6(7):321-41. PubMed ID: 10946997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrin-like substrate adhesion in RTG-2 cells, a fibroblastic cell line derived from rainbow trout.
    Reinhart B; Lee LE
    Cell Tissue Res; 2002 Feb; 307(2):165-72. PubMed ID: 11845323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A synthetic peptide from the heparin-binding domain III (repeats III4-5) of fibronectin promotes stress-fibre and focal-adhesion formation in melanoma cells.
    Moyano JV; Maqueda A; Albar JP; Garcia-Pardo A
    Biochem J; 2003 Apr; 371(Pt 2):565-71. PubMed ID: 12519080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis.
    Capo-Chichi CD; Smith ER; Yang DH; Roland IH; Vanderveer L; Cohen C; Hamilton TC; Godwin AK; Xu XX
    Cancer; 2002 Oct; 95(8):1802-15. PubMed ID: 12365030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of the local conformational properties of the cell-adhesion domain of collagen type IV in synthetic heterotrimeric peptides.
    Saccà B; Fiori S; Moroder L
    Biochemistry; 2003 Apr; 42(12):3429-36. PubMed ID: 12653546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A specific sequence of the noncollagenous domain of the alpha3(IV) chain of type IV collagen inhibits expression and activation of matrix metalloproteinases by tumor cells.
    Pasco S; Han J; Gillery P; Bellon G; Maquart FX; Borel JP; Kefalides NA; Monboisse JC
    Cancer Res; 2000 Jan; 60(2):467-73. PubMed ID: 10667602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.